Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Walter, RB; Othus, M; Löwenberg, B; Ossenkoppele, GJ; Petersdorf, SH; Pabst, T; Vekemans, M-C; Appelbaum, FR; Erba, HP; Estey, EH

Published Date

  • October 2015

Published In

Volume / Issue

  • 100 / 10

Start / End Page

  • e409 - e411

PubMed ID

  • 26160876

Pubmed Central ID

  • 26160876

Electronic International Standard Serial Number (EISSN)

  • 1592-8721

Digital Object Identifier (DOI)

  • 10.3324/haematol.2015.130013

Language

  • eng

Conference Location

  • Italy